| 2008
Biobootcamp Presenters
General Partner, Morgenthaler Ventures
Christoffersen
joined Morgenthaler Ventures in 2001. Based in Boulder, Colorado,
he is focusing on new biotechnology investments. Previously, he
was the President and CEO of Ribozyme Pharmaceuticals, Inc., a
Morgenthaler portfolio biotechnology company with a mission to
commercialize the Nobel Prize-winning discovery of ribozymes for
use as human therapeutics. He currently serves on six corporate
boards, and achieved successful exits with Threshold Pharmaceuticals,
Avidia Biosciences, and most recently Morphotek.
He also served as the Senior Vice President of Research at SmithKline
Beecham, and Vice President of Discovery Research at The Upjohn
Company, and President of Colorado State University.
Christoffersen received an honorary doctor of law degree from
Cornell College in 1983, the "Outstanding Research of Year"
Award from the International Society of Quantum Biology in 1981,
the "W. E. Upjohn Award" for contributions in biotechnology
in 1988, and a Lifetime Achievement Award in 2003 from the Colorado
Biosciences Association.
|
